Just came across this document that you’ll find on Scrib, which is a bit over my head, but quite sure some of the visitors to Chilmark Research will find it useful. A team comprised of UK NHS reps and others from the US put together the guide with the expressed intention of:
…provide guidance for the use of SNOMED CT in the HL7 V3 Clinical Statement model.
Leading healthcare IT industry analyst firm Chilmark Research today announced the formation of the company’s first-ever Advisory Board. This new committee was established to represent a variety of roles and experiences within the healthcare industry, ensuring diversity in both expertise and personal experiences with the U.S. healthcare ecosystem.
HIMSS’23 saw artificial intelligence in everyone’s booths and conversations. How do we ensure this tech is deployed thoughtfully and carefully?
After many years at the helm, Chilmark founder and CEO John Moore prepares for the next step, reflecting on a long and fruitful time here.
0 Comments